Back to search results

Observational Study on Cervical Cancer Screening and HPV Vaccination in Emergency Care

This study is looking at new ways to offer cervical cancer screening and education about the HPV (Human Papillomavirus) vaccine to women. HPV can cause cervical cancer. Researchers want to see if offering self-collection for HPV samples and HPV vaccination in emergency rooms can help more women get screened and vaccinated, especially those who might have trouble accessing regular healthcare. You may be able to join if you are a woman between 18 and 65 years old and have a Mayo Clinic medical record number. The study will measure how many women choose to self-collect HPV samples and how many get the HPV vaccine after visiting the emergency department. It will also interview women who decline self-collection. The current recruitment status is unclear.

Study design
This is an observational study planning to include 100 women. It is not testing a new drug or treatment.
What's involved
You would be asked to self-collect an HPV sample and potentially receive an HPV vaccination. There will also be interviews for women who decline self-collection.
Compensation
Not stated in the trial record.
Follow-up
HPV vaccination will be measured at one month after your emergency department visit. Interviews for women who decline self-collection will be at baseline.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06607874

Self-Collection for Cervical Cancer Screening and HPV Vaccination for Cancer Prevention Among Women in Emergency Care in Northeast Florida

Not Yet Recruiting
Not specifiedAges 18–65Observational
Mayo Clinic
~100 participants
Updated 2026-08-05 on ClinicalTrials.gov
What's tested:Non-Interventional Study

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Human Papilloma Virus (HPV) sample self-collection following Emergency Department (ED) presentation
Measured over Baseline
+4 more outcomes measured

Conditions

Human Papillomavirus-Related Cervical Carcinoma

Explore related trials

Cervical Carcinoma

Where it's being run

1 sites across 1 states
Florida1

Study leadership

  • Christopher C. DeStephano, MD, MPH · PRINCIPAL_INVESTIGATOR · Mayo Clinic

Who to contact

Clinical Trials Referral Office
[email protected]
855-776-0015
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adults assigned as female at birth age 18-65 with a Mayo Clinic medical record number

Exclusion

Adults assigned as female at birth age 0-17
Adults assigned as female at birth age \> 65
Adults assigned as male at birth
Adults assigned as female at birth without a Mayo Clinic medical record number

What this trial measures

  • Human Papilloma Virus (HPV) sample self-collection following Emergency Department (ED) presentationBaseline

    Will be assessed by the percentage of women between 25-65 eligible for cervical cancer screening who participate or who opt not to participate in self-collection.

  • HPV vaccination following ED presentationOne month

    Will be assessed by the percentage of women between 18-26 eligible for HPV vaccination for cervical cancer prevention who participate in HPV vaccination. Participants will be contacted one month after initial contact to determine if the HPV vaccination was administered.

  • Interviews of women who decline self-collectionBaseline

    Phone or video-based interviews will be conducted with eligible participants who decline self-collection to determine reasons for non-participation.

  • Interviews of women who consent to self-collection but do not complete the self-collectionUp to 6 weeks

    Phone or video-based interviews will be conducted with participants who agree to participate but do not complete self-collection after 4 weeks to determine reasons for non-participation.

  • Interviews of women who complete the self-collectionUp to 6 weeks

    Phone or video-based interviews will be conducted with participants who completed self-collection for feedback on the process.